Speaker illustration

Professor Edelgard Lindhoff-Last

(Germany)

Paradigm shift in DOAC reversal - What are the current therapeutic options?

Event: ESC Congress 2019

Topic: Pharmacology and Pharmacotherapy

Session type: Satellite Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb